|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weigelt B, Peterse JL and van 't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gray-Owen SD and Blumberg RS: CEACAM1:
Contact-dependent control of immunity. Nat Rev Immunol. 6:433–446.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prall F, Nollau P, Neumaier M, Haubeck HD,
Drzeniek Z, Helmchen U, Löning T and Wagener C: CD66a (BGP), an
adhesion molecule of the carcinoembryonic antigen family, is
expressed in epithelium, endothelium and myeloid cells in a wide
range of normal human tissues. J Histochem Cytochem. 44:35–41.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Neumaier M, Paululat S, Chan A, Matthaes P
and Wagener C: Biliary glycoprotein, a potential human cell
adhesion molecule, is down-regulated in colorectal carcinomas. Proc
Natl Acad Sci USA. 90:10744–10748. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka K, Hinoda Y, Takahashi H, Sakamoto
H, Nakajima Y and Imai K: Decreased expression of biliary
glycoprotein in hepatocellular carcinomas. Int J Cancer. 74:15–19.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kammerer R, Riesenberg R, Weiler C,
Lohrmann J, Schleypen J and Zimmermann W: The tumour suppressor
gene CEACAM1 is completely but reversibly downregulated in renal
cell carcinoma. J Pathol. 204:258–267. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Busch C, Hanssen TA, Wagener C and OBrink
B: Down-regulation of CEACAM1 in human prostate cancer: Correlation
with loss of cell polarity, increased proliferation rate and
Gleason grade 3 to 4 transition. Hum Pathol. 33:290–298. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nittka S, Gunther J, Ebisch C,
Erbersdobler A and Neumaier M: The human tumor suppressor CEACAM1
modulates apoptosis and is implicated in early colorectal
tumorigenesis. Oncogene. 23:9306–9313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Estrera VT, Chen DT, Luo W, Hixson DC and
Lin SH: Signal transduction by the CEACAM1 tumor suppressor.
Phosphorylation of serine 503 is required for growth-inhibitory
activity. J Biol Chem. 276:15547–15553. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang JL, Sun SZ, Qu X, Liu WJ, Wang YY, Lv
CX, Sun JZ and Ma R: Clinicopathological significance of CEACAM1
gene expression in breast cancer. Chin J Physiol. 54:332–338.
2011.PubMed/NCBI
|
|
12
|
Yang C, He P, Liu Y, He Y, Yang C, Du Y,
Zhou M, Wang W, Zhang G, Wu M and Gao F: Down-regulation of CEACAM1
in breast cancer. Acta Biochim Biophys Sin (Shanghai). 47:788–794.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riethdorf L, Lisboa BW, Henkel U, Naumann
M, Wagener C and Loning T: Differential expression of CD66a (BGP),
a cell adhesion molecule of the carcinoembryonic antigen family, in
benign, premalignant and malignant lesions of the human mammary
gland. J Histochem Cytochem. 45:957–963. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang J, Hardy JD, Sun Y and Shively JE:
Essential role of biliary glycoprotein (CD66a) in morphogenesis of
the human mammary epithelial cell line MCF10F. J Cell Sci.
112:4193–4205. 1999.PubMed/NCBI
|
|
15
|
Kirshner J, Chen CJ, Liu P, Huang J and
Shively JE: CEACAM1-4S, a cell-cell adhesion molecule, mediates
apoptosis and reverts mammary carcinoma cells to a normal
morphogenic phenotype in a 3D culture. Proc Natl Acad Sci USA.
100:521–526. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tavassoli FA and Devilee P: World Health
Organization classification of tumors Pathology and genetics of
tumors of the breast and female genital organs. Lyon: IARC Press;
2003
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oliveira-Ferrer L, Tilki D, Ziegeler G,
Hauschild J, Loges S, Irmak S, Kilic E, Huland H, Friedrich M and
Ergün S: Dual role of carcinoembryonic antigen-related cell
adhesion molecule 1 in angiogenesis and invasion of human urinary
bladder cancer. Cancer Res. 64:8932–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beauchemin N and Arabzadeh A:
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs)
in cancer progression and metastasis. Cancer Metastasis Rev.
32:643–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirshner J, Hardy J, Wilczynski S and
Shively JE: Cell-cell adhesion molecule CEACAM1 is expressed in
normal breast and milk and associates with beta1 integrin a 3D
model of morphogenesis. J Mol Histol. 35:287–299. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chakrabarti R, Hwang J, Blanco Andres M,
Wei Y, Lukačišin M, Romano RA, Smalley K, Liu S, Yang Q, Ibrahim T,
et al: Elf5 inhibits the epithelial -mesenchymal transition in
mammary gland development and breast cancer metastasis by
transcriptionally repressing Snail2. Nat Cell Biol. 14:1212–1222.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Said AH, Raufman JP and Xie G: The role of
matrix metalloproteinases in colorectal cancer. Cancers. 6:366–375.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Di G, Wu CT, Hu X and Duan H:
CEACAM1 inhibits cell-matrix adhesion and promotes cell migration
through regulating the expression of N-cadherin. Biochem Biophys
Res Commun. 430:598–603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hugo H, Ackland ML, Blick T, Lawrence MG,
Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal
and mesenchymal-epithelial transitions in carcinoma progression. J
Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo WP, Wood CG, Earley K, Hung MC and Lin
SH: Suppression of tumorigenicity of breast cancer cells by an
epithelial cell adhesion molecule (C-CAM1): The adhesion and growth
suppression are mediated by different domains. Oncogene.
14:1697–1704. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Obrink B: Is CEACAM1 a lymphangiogenic
switch? Blood. 110:4137–4138. 2007. View Article : Google Scholar
|
|
29
|
Ebrahimnejad A, Streichert T, Nollau P,
Horst AK, Wagener C, Bamberger AM and Brümmer J: CEACAM1 enhances
invasion and migration of melanocytic and melanoma cells. Am J
Pathol. 165:1781–1787. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu W, Wei W, Winer D, Bamberger AM,
Bamberger C, Wagener C, Ezzat S and Asa SL: CEACAM1 impedes thyroid
cancer growth but promotes invasiveness: A putative mechanism for
early metastases. Oncogene. 26:2747–2758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo W, Tapolsky M, Earley K, Wood CG,
Wilson DR, Logothetis CJ and Lin SH: Tumor-suppressive activity of
CD66a in prostate cancer. Cancer Gene Ther. 6:313–321. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volpert O, Luo W, Liu TJ, Estrera VT,
Logothetis C and Lin SH: Inhibition of prostate tumor angiogenesis
by the tumor suppressor CEACAM1. J Biol Chem. 277:35696–35702.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ieda J, Yokoyama S, Tamura K, Takifuji K,
Hotta T, Matsuda K, Oku Y, Nasu T, Kiriyama S, Yamamoto N, et al:
Re-expression of CEACAM1 long cytoplasmic domain isoform is
associated with invasion and migration of colorectal cancer. Int J
Cancer. 129:1351–1361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kiriyama S, Yokoyama S, Ueno M, Hayami S,
Ieda J, Yamamoto N, Yamaguchi S, Mitani Y, Nakamura Y, Tani M, et
al: CEACAM1 long cytoplasmic domain isoform is associated with
invasion and recurrence of hepatocellular carcinoma. Ann Surg
Oncol. 21 Suppl 4:S505–S514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stamenkovic I: Matrix metalloproteinases
in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cavallaro U and Christofori G: Cell
adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wheelock MJ, Shintani Y, Maeda M, Fukumoto
Y and Johnson KR: Cadherin switching. J Cell Sci. 121:727–735.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Theveneau E and Mayor R: Cadherins in
collective cell migration of mesenchymal cells. Curr Opin Cell
Biol. 24:677–684. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
